Double maintains 1 strategies that include TBPH - Theravance Biopharma, Inc.
Current Value
$11.571 Year Return
Current Value
$11.571 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KYMR | 44.50% | $3.15B | -7.38% | 0.00% |
BPMC | 41.66% | $8.36B | +7.34% | 0.00% |
VERA | 38.58% | $1.48B | -37.70% | 0.00% |
JMIA | 34.66% | $548.63M | -66.77% | 0.00% |
RGNX | 32.75% | $415.20M | -39.23% | 0.00% |
ADTN | 32.06% | $708.29M | +42.05% | 0.00% |
AUTL | 30.21% | $662.69M | -44.79% | 0.00% |
ARCT | 30.18% | $356.64M | -48.19% | 0.00% |
MODV | 30.13% | $44.50M | -88.08% | 0.00% |
NRIX | 29.65% | $928.86M | -46.73% | 0.00% |
BNTX | 29.57% | $26.60B | +27.45% | 0.00% |
CAE | 29.50% | $9.46B | +53.06% | 0.00% |
KURA | 29.06% | $530.70M | -73.61% | 0.00% |
VYGR | 29.00% | $170.16M | -66.17% | 0.00% |
ATKR | 28.58% | $2.45B | -52.32% | 1.79% |
CLF | 28.34% | $4.49B | -43.06% | 0.00% |
CHGG | 28.27% | $142.80M | -63.98% | 0.00% |
SIMO | 28.04% | $2.40B | -10.64% | 2.82% |
ANIK | 28.03% | $157.76M | -61.47% | 0.00% |
RCEL | 27.84% | $132.91M | -48.56% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LUMN | -25.00% | $4.65B | +243.18% | 0.00% |
KVUE | -24.16% | $41.07B | +17.21% | 3.83% |
NCMI | -15.19% | $449.83M | -5.54% | 0.63% |
YOU | -13.34% | $2.69B | +41.92% | 1.63% |
BVS | -13.11% | $437.96M | -8.33% | 0.00% |
SAIC | -13.08% | $5.23B | -9.35% | 1.31% |
UTZ | -12.69% | $1.18B | -12.89% | 1.74% |
EDU | -12.60% | $8.35B | -30.01% | 0.00% |
BAX | -12.01% | $14.50B | -20.51% | 2.82% |
RILY | -10.47% | $140.90M | -73.49% | 0.00% |
MKTX | -9.96% | $8.05B | -3.20% | 1.40% |
FE | -9.32% | $23.33B | +3.75% | 4.26% |
CHD | -9.31% | $23.52B | -6.66% | 1.20% |
ALHC | -9.30% | $2.62B | +34.35% | 0.00% |
JJSF | -9.12% | $2.21B | -31.42% | 2.74% |
ED | -9.11% | $36.01B | +9.18% | 3.35% |
CL | -9.11% | $71.44B | -9.50% | 2.29% |
COKE | -8.97% | $8.56B | +1.11% | 7.25% |
CI | -8.95% | $80.79B | -10.97% | 1.93% |
CCI | -8.25% | $44.40B | -1.88% | 5.61% |
Yahoo
Viatris Inc. (NASDAQ:VTRS) is one of the best low priced pharma stocks to buy now. On June 27, Viatris received approval from China’s National Medical Products Administration/NMPA for Yupelri (revefenacin) inhalation solution for the maintenance treatment of chronic obstructive pulmonary disease/COPD. Yupelri is the first ever once-daily nebulized long-acting muscarinic antagonist/LAMA approved in China for […]
Yahoo
Theravance Biopharma, Inc. ( NASDAQ:TBPH ) is possibly approaching a major achievement in its business, so we would...
Finnhub
Theravance Biopharma, Inc. dropped from Russell 2000 Value-Defensive Index...
Finnhub
Theravance Biopharma, Inc. dropped from Russell 2000 Defensive Index...
Finnhub
Theravance Biopharma, Inc. added to Russell 3000 Growth Index...
Finnhub
Theravance Biopharma, Inc. added to Russell Small Cap Comp Growth Index...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DAO | -<0.01% | $277.77M | +143.29% | 0.00% |
REYN | 0.02% | $4.52B | -20.88% | 4.24% |
MTN | -0.02% | $5.94B | -12.57% | 5.54% |
EXEL | -0.03% | $12.02B | +93.59% | 0.00% |
RKT | 0.05% | $2.01B | -9.49% | 0.00% |
CWEN.A | -0.05% | $3.58B | +27.81% | 5.61% |
TRUG | 0.05% | $5.44M | -89.94% | 0.00% |
OHI | -0.06% | $11.00B | +6.44% | 7.03% |
IMNN | -0.08% | $10.81M | -62.28% | 0.00% |
GIS | 0.10% | $27.13B | -20.49% | 4.81% |
ARRY | -0.10% | $1.13B | -36.74% | 0.00% |
ES | -0.11% | $23.78B | +8.37% | 4.52% |
MODG | 0.11% | $1.61B | -43.68% | 0.00% |
FLO | -0.14% | $3.25B | -29.91% | 6.23% |
EW | 0.14% | $45.06B | -12.45% | 0.00% |
WLK | 0.15% | $10.48B | -45.29% | 2.56% |
ADUS | 0.16% | $2.01B | -10.91% | 0.00% |
CHT | -0.17% | $34.13B | +20.55% | 3.76% |
WPC | -0.19% | $13.51B | +5.89% | 5.72% |
LKQ | -0.20% | $9.68B | -17.35% | 3.19% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SHV | -0.04% | $20.75B | 0.15% |
IEI | 0.05% | $15.66B | 0.15% |
IEF | 0.05% | $34.86B | 0.15% |
IBTM | -0.06% | $316.67M | 0.07% |
CANE | 0.12% | $11.33M | 0.29% |
VGSH | 0.19% | $22.74B | 0.03% |
VGIT | -0.20% | $31.76B | 0.04% |
LMBS | 0.21% | $5.12B | 0.64% |
BIL | 0.23% | $41.80B | 0.1356% |
GCOR | 0.25% | $588.67M | 0.08% |
CGMU | 0.27% | $3.39B | 0.27% |
IBTI | -0.29% | $1.07B | 0.07% |
JMUB | 0.31% | $3.09B | 0.18% |
CMF | -0.33% | $3.50B | 0.08% |
JPLD | 0.36% | $2.07B | 0.24% |
IBMP | -0.38% | $553.96M | 0.18% |
FMB | 0.38% | $1.89B | 0.65% |
BILZ | 0.40% | $838.22M | 0.14% |
SPTI | 0.41% | $8.66B | 0.03% |
FLGV | 0.41% | $1.02B | 0.09% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -23.97% | $310.74M | 1.43% |
VIXY | -14.30% | $198.83M | 0.85% |
TAIL | -13.69% | $94.79M | 0.59% |
UUP | -9.59% | $187.70M | 0.77% |
USDU | -9.10% | $130.22M | 0.5% |
TPMN | -8.99% | $31.00M | 0.65% |
PSQA | -8.29% | $36.50M | 0.2% |
SMMU | -8.07% | $899.05M | 0.35% |
ICSH | -7.84% | $5.96B | 0.08% |
JUCY | -7.18% | $256.64M | 0.6% |
TFLO | -7.06% | $6.74B | 0.15% |
BOXX | -6.90% | $6.96B | 0.19% |
IBMO | -6.30% | $527.52M | 0.18% |
MEAR | -6.29% | $1.14B | 0.25% |
BILS | -6.13% | $3.81B | 0.1356% |
IVOL | -6.12% | $342.76M | 1.02% |
FLMI | -5.48% | $744.72M | 0.3% |
AGZ | -5.47% | $609.97M | 0.2% |
VIXM | -5.27% | $23.12M | 0.85% |
DFNM | -4.19% | $1.58B | 0.17% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 32.90% | $5.07B | 0.35% |
GNOM | 30.39% | $44.39M | 0.5% |
IBB | 29.83% | $5.48B | 0.45% |
ARKG | 28.86% | $1.06B | 0.75% |
PBE | 27.83% | $229.54M | 0.58% |
QDVO | 27.06% | $94.53M | 0.55% |
IPAC | 27.03% | $1.74B | 0.09% |
FTLS | 26.53% | $1.99B | 1.38% |
PIZ | 26.23% | $377.60M | 0.8% |
EWJ | 26.01% | $14.90B | 0.5% |
JPXN | 25.99% | $93.02M | 0.48% |
BBJP | 25.92% | $12.76B | 0.19% |
QFLR | 25.91% | $299.90M | 0.89% |
IMTM | 25.77% | $3.06B | 0.3% |
PPI | 25.69% | $57.19M | 0.78% |
PDN | 25.57% | $359.32M | 0.47% |
GRID | 25.50% | $2.70B | 0.56% |
FFTY | 25.38% | $78.67M | 0.8% |
IWC | 25.38% | $831.95M | 0.6% |
JIRE | 25.25% | $7.74B | 0.24% |